SYNAIRGEN PLCSYNAIRGEN PLCSYNAIRGEN PLC

SYNAIRGEN PLC

No trades
See on Supercharts

SNGL fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Synairgen Plc is a holding company, which engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease, and severe viral infections. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

SNGL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company